ROBERT J DELUCCIA
CIK 1127423 · Executive Chairman · last filed 2026-04-22
ROBERT J DELUCCIA is an Executive Chairman who has filed 16 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for ACXP, was dated Apr 22, 2026. Across all open-market trades the lifetime net is +$174.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.59M
3
16
$174.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACXP | Director | 1,014,043 | $1.57 | $1.59M | $149.7K | 9 | 2026-04-22 |
| PLx Pharma Inc. (PLXP) Delisted | Executive Chairman | — | $0.09 | — | $0 | 1 | 2017-04-20 |
| PLx Pharma Inc. (DPRX) Delisted | Executive Chairman | 1,831,309 | — | — | $25.0K | 3 | 2016-01-21 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-22 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2025-02-06 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2025-01-08 | ACXP | Buy (P) | +49,261 | $50.0K | EDGAR |
| 2024-04-03 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2024-01-04 | ACXP | Mixed | −90,263 | $70.1K | EDGAR |
| 2023-02-24 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2022-07-29 | ACXP | Buy (P) | +19,737 | $75.0K | EDGAR |
| 2021-11-22 | ACXP | Buy (P) | +5,034 | $24.7K | EDGAR |
| 2021-07-06 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2017-04-20 | PLx Pharma Inc. (PLXP) Delisted | Grant (A) | — | $0 | EDGAR |